Financials
- Market Capitalization 485.31 M
- Employee 87
- Founded N/A
- CEO N/A
- Website www.editasmedicine.com
- Headquarter Delaware, United States
- FIGI BBG005MX5GZ2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.14
売上高対価格比率
4.49
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2892 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.03 USD | -1.62% | -7.62% | -0.98% | +56.19% | 524.62 M USD | ||
| 2899 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.37 USD | -3.13% | +0.60% | +15.61% | +133.15% | 517.63 M USD | ||
| 2943 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.36% | +20.95% | -23.67% | 479.78 M USD | ||
| 2944 | PRTA Prothena Corporation plc - Ordinary Shares | 9.33 USD | +2.64% | -1.37% | +9.76% | +14.20% | 478.97 M USD |